ICD-11 Criteria for Mild Neurocognitive Disorder (6D71)
Mild neurocognitive disorder is
characterized by mild impairment in one or more cognitive domains relative to
that expected given the individual’s age and general premorbid level of
cognitive functioning, which represents a decline from the individual’s
previous level of functioning. Diagnosis is based on report from the patient,
informant, or clinical observation, and is accompanied by objective evidence of
impairment by quantified clinical assessment or standardized cognitive testing.
Cognitive impairment is not severe enough to significantly interfere with an
individual’s ability to perform activities related to personal, family, social,
educational, and/or occupational functioning or other important functional
areas. Cognitive impairment is not attributable to normal aging and may be
static, progressive, or may resolve or improve depending on underlying cause or
treatment. Cognitive impairment may be attributable to an underlying acquired
disease of the nervous system, a trauma, an infection or other disease process
affecting the brain, use of specific substances or medications, nutritional
deficiency or exposure to toxins, or the etiology may be undetermined. The
impairment is not due to current substance intoxication or withdrawal.
Coding Note: Code aslo the causing condition
REFERENCE:
International Classification of Diseases Eleventh Revision (ICD-11). Geneva: World Health Organization; 2022. License: CC BY-ND 3.0 IGO.
https://creativecommons.org/licenses/by-nc-nd/3.0/igo/
Comments
Post a Comment
Your Thoughts?